EW Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: February 26, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Edwards Lifesciences Corp (EW)

Based on 43 analysts giving stock ratings to Edwards Lifesciences Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
26
Buy
46
Hold
28
Sell
0
Strong Sell
0
Edwards Lifesciences Corp

Edwards Lifesciences Corp. Stock Analysis EW

United States Health Care Large Cap Report:
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Read More

Edwards Lifesciences Corp (EW) Chart

Key Statistics of Edwards Lifesciences Corp (EW)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$81.36$82.77

Today's Open

$82.02

Volume

4.66M

P/E Ratio (TTM)

44.52

52 Week Range

$65.94$87.89

Market Cap

47.21B

Avg. Volume

4.43M

Dividend Yield

-

Financial Metrics & Statements of Edwards Lifesciences Corp (EW)

FAQ's for Edwards Lifesciences Corp (EW)

  • According to Musaffa’s Shariah screening methodology, Edwards Lifesciences Corp (EW) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.